No Data
The first real-world research standards in the health food Industry have been released, and By-health Co., Ltd. is the first to conduct real-world research on products.
Guangzhou, February 28, 2025 /PR Newswire/ -- On February 28, the China Nutrition and Health Food Association officially released the industry's first real-world research standard — "Guidelines for Real-World Research on Health Food." This standard was primarily drafted by the School of Public Health at Sun Yat-sen University, the China National Institute of Standardization, the Health Food R&D Professional Committee of the China Nutrition and Health Food Association, and By-health Co., Ltd. It took three years to develop. It references the real-world research system in the pharmaceutical field and aims to provide scientific methods and technical guidance for the evaluation of the functions and safety of health foods after they are marketed, filling a gap in the industry in this area.
By-health Co., Ltd. (300146.SZ): Obtained a commitment letter for share buyback loans from financial institutions.
On February 26, Gelonghui reported that By-health Co., Ltd. (300146.SZ) announced it has recently received a "Financing Commitment Letter" issued by the Guangzhou Branch of Industrial And Commercial Bank Of China, with the main contents as follows: 1. Loan amount: no more than 180 million yuan; 2. Loan term: no more than 36 months; 3. Loan purpose: specifically used to repurchase company Stocks; 4. Validity period of the commitment letter: 1 year from the date of issuance.
Investors Holding Back On Byhealth Co., Ltd (SZSE:300146)
By-health Co., Ltd. (300146.SZ): First repurchase of 0.888 million shares.
On February 6, Gelonghui reported that By-health Co., Ltd. (300146.SZ) announced that on February 5, 2025, the company first implemented this repurchase through a special securities repurchase account via centralized bidding, repurchasing a total of 888,000 shares, accounting for 0.0522% of the company's total share capital, with a highest Fill Price of 11.28 yuan/share, a lowest Fill Price of 11.23 yuan/share, and a total payment amount of 9,993,993.00 yuan (excluding transaction fees). This repurchase complies with relevant laws and regulations and aligns with the company's established repurchase plan.
By-health Co., Ltd. (300146.SZ): It is estimated that the net income in 2024 will decrease by 55.33% to 68.51% year-on-year.
Glory Exchange on January 24 reports that By-health Co., Ltd. (300146.SZ) announced an expected net income of 550 million yuan to -780 million yuan for 2024, a decrease of 55.33% to 68.51% compared to the same period last year. The non-recurring net income is expected to be between 500 million yuan and -750 million yuan, a decline of 53.04% to 68.69% compared to the same period last year. 1. In 2024, the company will adhere to a strong Technology and strong brand Global Strategy, continuously promoting the implementation of "scientific nutrition" and more professional product innovation strategies centered on Consumer health value. During the reporting period, the consumption environment continued to change, and industry competition intensified.
Tomson Beijian: 2024 Annual Results Forecast
Byhealth Co., Ltd (SZSE:300146) Just Reported Earnings, And Analysts Cut Their Target Price
